Found 30 matching trials
Combination Chemotherapy and Rituximab in Treating Patients With Newly Diagnosed Burkitt's Lymphoma or Leukemia PHASE2 RATIONALE: Drugs used in chemotherapy, work in different ways to stop the g...
Show More Location
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Learn More & Join Trial
Open Label Multicenter Study of CVP Followed by Iodine-131 Anti-B1 Antibody for Subjects With Untreated Low-Grade Non Hodgkin's Lymphoma. PHASE2 This is a phase II, open-label, multicenter study of the efficacy and safet...
Show More Location
Multiple Locations
Learn More & Join Trial
Phase 3 Study of Zevalin Following R-CVP in Previously Untreated Patients With Follicular Non Hodgkin's Lymphoma (NHL) PHASE3 This study will treat follicular lymphoma patients who have not received pr...
Show More Location
Integrated Community Oncology Network
Learn More & Join Trial
Shortened vs Standard Chemotherapy Combined With Immunotherapy for the Initial Treatment of Patients With High Tumor Burden Follicular Lymphoma PHASE3 FIL\_FOLL19 is an open-label, multicenter, randomized phase III trial. The ...
Show More Status
Active Not Recruiting
Location
IRCCS Istituto Romagnolo per lo studio dei Tumori "Dino Amadori" - IRST S.R.L. - Ematologia
Learn More & Join Trial
A Study to Evaluate Safety, Efficacy and Pharmacokinetics of Rituximab (MabThera/Rituxan) in Participants With Diffuse Large B Cell Lymphoma (DLBCL) or Follicular Lymphoma (FL) PHASE3 This single arm, multicenter study will evaluate the safety, efficacy and p...
Show More Location
Irccs Ist. Tumori Giovanni Paolo Ii; Dipartimento Oncologia Medica
Learn More & Join Trial
Treatment of Elderly Patients With Diffuse Large B-cell Lymphoma PHASE4 To explore the clinical features and efficacy evaluation of large b-cell ly...
Show More Location
Oncology Department of The First Affiliated Hospital of Zhengzhou University
Learn More & Join Trial
To Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparison With Rituxan PHASE3 This study is a Phase 3 prospective, randomised, parallel-group, active con...
Show More Location
Multiple Locations
Learn More & Join Trial
An Open-Label, Single Arm Study of Obinutuzumab Short Duration Infusion in Patients With Previously Untreated Advanced Follicular Lymphoma PHASE4 This open-label, single arm study will evaluate the safety of obinutuzumab ...
Show More Location
Rocky Mountain Cancer Center; Medical Oncology
Learn More & Join Trial
A Study of Participant Preference With Subcutaneous Versus Intravenous MabThera/Rituxan in Participants With CD20+ Diffuse Large B-Cell Lymphoma or CD20+ Follicular Non-Hodgkin's Lymphoma Grades 1, 2 or 3a PHASE3 This multi-center, open-label, randomized study will evaluate the participa...
Show More Location
Multiple Locations
Learn More & Join Trial
First-line R-CVP vs R-CHOP Induction Immunochemotherapy for Indolent Lymphoma and R Maintenance. PHASE3 Evaluation of event free survival (EFS) of patients treated with the study ...
Show More Location
Podkarpacki Oncology Centre
Learn More & Join Trial